Lack of Replication of the -by-Coffee Interaction in Parkinson Disease

article has not abstract

Vyšlo v časopise: Lack of Replication of the -by-Coffee Interaction in Parkinson Disease. PLoS Genet 10(11): e32767. doi:10.1371/journal.pgen.1004788
Kategorie: Formal Comment
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1004788

Souhrn

article has not abstract

Zdroje

1. ManolioTA, CollinsFS, CoxNJ, GoldsteinDB, HindorffLA, et al. (2009) Finding the missing heritability of complex diseases. Nature 461 : 747–753.

2. LillCM, RoehrJT, McQueenMB, KavvouraFK, BagadeS, et al. (2012) Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database. PLoS Genet 8: e1002548.

3. NoyceAJ, BestwickJP, Silveira-MoriyamaL, HawkesCH, GiovannoniG, et al. (2012) Meta-analysis of early nonmotor features and risk factors for Parkinson disease. Ann Neurol 72 : 893–901.

4. QiH, LiS (2013) Dose-response meta-analysis on coffee, tea and caffeine consumption with risk of Parkinson's disease. Geriatr Gerontol Int 1–10.

5. ShookBC, JacksonPF (2011) Adenosine A(2A) Receptor Antagonists and Parkinson's Disease. ACS Chem Neurosci 2 : 555–567.

6. KraftP, YenY-C, StramDO, MorrisonJ, GaudermanWJ (2007) Exploiting gene-environment interaction to detect genetic associations. Hum Hered 63 : 111–119.

7. HamzaTH, ChenH, Hill-BurnsEM, RhodesSL, MontimurroJ, et al. (2011) Genome-wide gene-environment study identifies glutamate receptor gene GRIN2A as a Parkinson's disease modifier gene via interaction with coffee. PLoS Genet 7: e1002237.

8. ThomasD (2010) Gene–environment-wide association studies: emerging approaches. Nat Rev Genet 11 : 259–272.

9. ThomasDC, LewingerJP, MurcrayCE, GaudermanWJ (2012) Invited commentary: GE-Whiz! Ratcheting gene-environment studies up to the whole genome and the whole exposome. Am J Epidemiol 175 : 203–207.

10. AminN, ByrneE, JohnsonJ, Chenevix-TrenchG, WalterS, et al. (2012) Genome-wide association analysis of coffee drinking suggests association with CYP1A1/CYP1A2 and NRCAM. Mol Psychiatry 17 : 1116–1129.

11. YangQ, KhouryMJ, FlandersWD (1997) Sample size requirements in case-only designs to detect gene-environment interaction. Am J Epidemiol 146 : 713–720.

12. MukherjeeB, ChatterjeeN (2008) Exploiting gene-environment independence for analysis of case-control studies: an empirical Bayes-type shrinkage estimator to trade-off between bias and efficiency. Biometrics 64 : 685–694.

13. WermuthL, LassenCF, HimmerslevL, OlsenJ, RitzB (2012) Validation of hospital register-based diagnosis of Parkinson's disease. Dan Med J 59: A4391.

14. MorimotoLM, WhiteE, NewcombPA (2003) Selection bias in the assessment of gene-environment interaction in case-control studies. Am J Epidemiol 158 : 259–263.

15. WitteJS, GaudermanWJ, ThomasDC (1999) Asymptotic bias and efficiency in case-control studies of candidate genes and gene-environment interactions: basic family designs. Am J Epidemiol 149 : 693–705.

16. WangY, LocalioR, RebbeckTR (2006) Evaluating bias due to population stratification in epidemiologic studies of gene-gene or gene-environment interactions. Cancer Epidemiol Biomarkers Prev 15 : 124–32.

17. FayardC, BonaventureA, BenatruI, RozeE, DumurgierJ, et al. (2011) Impact of recommendations on the initial therapy of Parkinson's disease: a population-based study in France. Parkinsonism Relat Disord 17 : 543–546.

18. BowerJH, MaraganoreDM, McDonnellSK, RoccaWA (1999) Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976–1990. Neurology 52 : 1214–1220.

19. CheckowayH, PowersK, Smith-WellerT, FranklinGM, LongstrethWT, et al. (2002) Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake. Am J Epidemiol 155 : 732–738.

20. Searles NielsenS, CheckowayH, ButlerRA, NelsonHH, FarinFM, et al. (2012) LINE-1 DNA methylation, smoking and risk of Parkinson's disease. J Parkinsons Dis 2 : 303–308.

21. MaraganoreDM, de AndradeM, LesnickTG, StrainKJ, FarrerMJ, et al. (2005) High-resolution whole-genome association study of Parkinson disease. Am J Hum Genet 77 : 685–693.

22. FacherisMF, SchneiderNK, LesnickTG, de AndradeM, CunninghamJM, et al. (2008) Coffee, caffeine-related genes, and Parkinson's disease: a case-control study. Mov Disord 23 : 2033–2040.

23. Searles NielsenS, FranklinGM, LongstrethWT, SwansonPD, CheckowayH (2013) Nicotine from edible Solanaceae and risk of Parkinson disease. Ann Neurol 74 : 472–477.

24. GaudermanWJ (2002) Sample size requirements for association studies of gene-gene interaction. Am J Epidemiol 155 : 478–484.

25. HubermanM, LangholzB (1999) Re: “Combined analysis of matched and unmatched case-control studies: comparison of risk estimates from different studies”. Am J Epidemiol 150 : 219–220.

26. MorenoV, MartínML, BoschFX, de SanjoséS, TorresF, et al. (1996) Combined analysis of matched and unmatched case-control studies: comparison of risk estimates from different studies. Am J Epidemiol 143 : 293–300.

27. BottoLD, KhouryMJ (2001) Commentary: facing the challenge of gene-environment interaction: the two-by-four table and beyond. Am J Epidemiol 153 : 1016–1020.

28. Tchetgen TchetgenEJ, KraftP (2011) On the robustness of tests of genetic associations incorporating gene-environment interaction when the environmental exposure is misspecified. Epidemiology 22 : 257–261.

29. WeinbergCR (1986) Applicability of the simple independent action model to epidemiologic studies involving two factors and a dichotomous outcome. Am J Epidemiol 123 : 162–173.